Slow Burn: US FDA RMAT Designations Surge While Breakthrough Pace Softens

 
• By Bridget Silverman
data increasing
RMAT designations are growing while Breakthrough Therapy designations appear to have passed their peak, according to Pink Sheet data. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers